Key Features High-purity lyophilized peptide Batch-specific Certificate of Analysis included Manufactured under strict quality standards Suitable for controlled laboratory research Packaged for professional handling environments Technical Specifications Compound: BPC-157 Format: Lyophilized powder Strength: 10 mg per vial Purity: 9899% (COA included) Appearance: White powder Category: Research peptide reagent Intended Use This product is intended strictly for: Laboratory research In-vitro studies Biochemical analysis Preclinical model research Not intended for: Human or animal use Injection, ingestion, inhalation, or topical application Medical, therapeutic, diagnostic, or cosmetic purposes This compound is not approved by Health Canada or any regulatory authority for clinical use
Sources & References 1RPEP-13892Vasireddi, Nikhil et al
This page, however, covers only the reconstitution math of the lyophilized powder for subcutaneous-style research workflows
These washout periods, which have been updated slightly since the 2022 List documents were published on 30 September to incorporate the latest scientific information, are highlighted in the revised version of the Summary of Major Modifications and Explanatory Note, and are based on the use of these medications according to the maximum manufacturers licensed doses
Best Practices for Subcutaneous Injection Choose a clean siteabdomen, outer thigh, or upper armand rotate daily to prevent irritation
a suitable subject or patient in need of therapy is identified by, for example, a health care professional or professionals using known tests, measurements or criteria
